American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.

American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.

Item
http://www.wikidata.org/entity/Q34236446
Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.Survey and Risk Factors for Lower Urinary Tract Storage Symptoms in Middle-Aged and Older Stroke Patients in Urban China.A Review of Adverse Events Related to Prostatic Artery Embolization for Treatment of Bladder Outlet Obstruction Due to BPH.Inter-Observer, Intra-Observer and Intra-Individual Reliability of Uroflowmetry Tests in Aged Men: A Generalizability Theory Approach.High-mobility group box 1 is involved in the development of benign prostatic hyperplasia with chronic prostatic inflammation.Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.
P2860

American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.

Item
http://www.wikidata.org/entity/Q34236446
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
American Urological Associatio ...... tatic hypertrophy: revisited.
@ast
American Urological Associatio ...... tatic hypertrophy: revisited.
@en
American Urological Associatio ...... tatic hypertrophy: revisited.
@nl
type
label
American Urological Associatio ...... tatic hypertrophy: revisited.
@ast
American Urological Associatio ...... tatic hypertrophy: revisited.
@en
American Urological Associatio ...... tatic hypertrophy: revisited.
@nl
prefLabel
American Urological Associatio ...... tatic hypertrophy: revisited.
@ast
American Urological Associatio ...... tatic hypertrophy: revisited.
@en
American Urological Associatio ...... tatic hypertrophy: revisited.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
American Urological Associatio ...... tatic hypertrophy: revisited.
@en
P2093
P304
P31
P356
10.1097/MOU.0B013E32834D8E87
P433
P478
P577
P698